Idioma:

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection

Molina, J.M. ; Delaugerre, C. ; Le Goff, J. ; Mela-Lima, B. ; Ponscarme, D. ; Goldwirt, L. ; de Castro, N.

Médecine et maladies infectieuses, 2020-06, Vol.50 (4), p.384-384

Texto completo disponível

Citações Citado por

Título:
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Autor: Molina, J.M. ; Delaugerre, C. ; Le Goff, J. ; Mela-Lima, B. ; Ponscarme, D. ; Goldwirt, L. ; de Castro, N.
Assuntos: Adult ; Aged ; Antiviral Agents - therapeutic use ; Azithromycin ; Azithromycin - therapeutic use ; Betacoronavirus - isolation & purification ; Coronavirus Infections - therapy ; COVID-19 ; Drug Therapy, Combination - standards ; Female ; Humans ; Hydroxychloroquine ; Hydroxychloroquine - therapeutic use ; Male ; Middle Aged ; Pandemics ; Pneumonia, Viral - therapy ; SARS-CoV-2 ; Treatment Outcome ; Young Adult
É parte de: Médecine et maladies infectieuses, 2020-06, Vol.50 (4), p.384-384
Notas: SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Feature-1
ObjectType-Correspondence-3
Editor: France: Elsevier Masson SAS
Idioma: Inglês;Francês

Links

Voltar para lista de resultados